Nakanishi Inc.
7.70
EUR
0.00
(0.00%)
ISIN
JP3642500007
Return %
Stock
S&P 500
1Y
35.09
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
JPY
•
in mil. unless spec.Working Capital
JPY
•
in mil. unless spec.Growth Rates
JPY
•
in mil. unless spec.Quarterly Revenue
JPY
•
in mil. unless spec.Quarterly Earnings Per Share
JPY
•
in mil. unless spec.Quarterly Dividends Per Share
JPY
•
in mil. unless spec.Company Description
- CEO
- Eiichi Nakanishi
- Full Time Employees
- 2,204
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- 700 Shimohinata Kanuma TO Japan 322-8666
- IPO Date
- Jul 19, 2000
- Website
- japan.nsk-dental.com
- Similar Companies
- Business
- Nakanishi Inc. (7716.T) manufactures and sells precision dental, surgical, and general industrial products worldwide, leveraging proprietary ultra-high-speed rotation and ultrasonic technologies. The company offers an extensive range of dental products including handpieces, air turbines, contra-angles, therapeutic motors, dental chairs, oral hygiene products, endotherapy devices, oral surgery systems, maintenance tools, and autoclaves; surgical products such as micro-motors and ultrasonic cutters for minimally invasive procedures; and industrial equipment encompassing ultra-precision spindles for automotive, smartphone, aircraft, and medical device manufacturing, as well as electric micro grinders and ultrasonic cutters for deburring, mold making, crafts, and jewelry. Founded in February 1930 and headquartered in Kanuma, Tochigi, Japan, Nakanishi operates globally through subsidiaries and sales networks in North America, Europe, Asia, and other regions, targeting dentists, oral surgeons, medical professionals, and industrial manufacturers. In recent years, Nakanishi has pursued strategic acquisitions to bolster its dental and surgical segments, including full ownership of U.S.-based DCI International, LLC, the second-largest dental chair manufacturer, in August 2023, which contributed significantly to revenue growth through enhanced U.S. market presence and bundled sales; and 100% acquisition of Guilin Refine Medical Instrument Co., Ltd. in China via subsidiary NSK Shanghai in November 2023, expanding dental equipment capabilities. Earlier acquisitions include German high-frequency spindle maker Alfred Jäger GmbH (now NAKANISHI Jaeger) in 2022 and others like Dental X and Integration Diagnostics Sweden, strengthening core grinding technologies and global sales infrastructure. These moves, alongside forex impacts and organic growth, drove consolidated net sales to 77.04 billion yen for the fiscal year ended December 31, 2024, with ongoing efforts to expand surgical business via new handpieces for minimally invasive surgery and partnerships with robot manufacturers.